Table of Contents Author Guidelines Submit a Manuscript
Stroke Research and Treatment
Volume 2011, Article ID 721613, 5 pages
http://dx.doi.org/10.4061/2011/721613
Research Article

Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial

1Shaheed Beheshti University of Medical Sciences and Health Services, Tehran 19839-63113, Iran
2Department of Neurology, Loghman Hospital, Shahid Beheshti University of Medical Sciences, Tehran 13336-31151, Iran
3Tehran University of Medical Sciences and Health Services, Tehran, Iran
4Gylan University of Medical Sciences and Health Services, Gylan, Iran
5Milad Hospital, Tehran, Iran
6Social Security, Tehran, Iran
7Azad University of Medical Sciences, Tehran 19168, Iran

Received 7 October 2010; Revised 22 February 2011; Accepted 26 April 2011

Academic Editor: Daniel Bereczki

Copyright © 2011 A. A. Harandi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

A. A. Harandi, R. Abolfazli, A. Hatemian, et al., “Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial,” Stroke Research and Treatment, vol. 2011, Article ID 721613, 5 pages, 2011. https://doi.org/10.4061/2011/721613.